Primary Site >> Colorectal Cancer
Gene >> PSMB9
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
|
Ref: Functional deficiencies of components of the MHC class I antigen pathway in human tumors of epithelial origin. PMID: 10933198 Ref: Overexpression of Cdx1 and Cdx2 homeogenes enhances expression of the HLA-I in HT-29 cells. PMID: 10964750 |
Ref: Impaired expression of proteasome subunits and human leukocyte antigens class I in human colon cancer cells. PMID: 12519221 Ref: Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: beta2-microglobulin inactivation in MSI-positive tumors and LMP7/TAP2 downregulation in MSI-negative tumors. PMID: 12694570 |
Ref: MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma. PMID: 14750179 |
Ref: Correlation between expression of major histocompatibility complex class I and that of antigen presenting machineries in carcinoma cell lines of the pancreas, biliary tract and colon. PMID: 16855371 |
Ref: Proinflammatory cytokines cause FAT10 upregulation in cancers of liver and colon. PMID: 18574467 Ref: Ten recently identified associations between nsSNPs and colorectal cancer could not be replicated in German families. PMID: 18619730 |
Ref: Chemotherapeutic agents in low noncytotoxic concentrations increase immunogenicity of human colon cancer cells. PMID: 21290210 Ref: Methylation-specific ligation detection reaction (msLDR): a new approach for multiplex evaluation of methylation patterns. PMID: 21879293 Ref: The LMP7-K allele of the immunoproteasome exhibits reduced transcript stability and predicts high risk of colon cancer. PMID: 22037870 |
Ref: PSMB9 codon 60 polymorphisms have no impact on the activity of the immunoproteasome catalytic subunit B1i expressed in multiple types of solid cancer. PMID: 24040045 |
Ref: Transcriptomic analysis reveals the underlying pro-malignant functions of Gankyrin for colorectal cancer via affecting tumor necrosis factor pathway. PMID: 29883699 |